Abstract
Inferring driving regulatory programs from comparative gene expression analysis is a cornerstone of systems biology. However, existing approaches are susceptible to biases inherent in real-world annotations, such as "promiscuous" genes that appear in numerous pathways. We present pyPAGE, an information-theoretic framework that uses conditional mutual information to account for these biases. Applying pyPAGE to Alzheimer’s Disease (AD) datasets, we identified cell-type-specific regulatory signatures and post-transcriptional programs that predict patient survival more accurately than traditional clinical metrics.
The Challenge of Annotation Bias
In systems biology, Gene-Set Enrichment Analysis (GSEA) is used to identify active biological "programs" in disease states. A significant hurdle is annotation bias: some genes are extensively studied or multifunctional, appearing in hundreds of annotations. If these "promiscuous" genes change expression, standard tools may report dozens of false-positive pathway perturbations. Conversely, these hubs can obscure signals from more specific, less-studied genes.
As shown in the figure above, there is a clear correlation between a gene's citation index and its gene-set membership, confirming that our biological maps are skewed by research effort.
The pyPAGE Framework
To address this, pyPAGE extends the iPAGE toolset by shifting from simple Mutual Information (MI) to Conditional Mutual Information (CMI). Instead of asking if gene expression is linked to a pathway, pyPAGE asks if that link remains significant given the total number of pathways those genes belong to.
Key features include:
- Distribution-Free: Handles both discrete (cell clusters) and continuous (fold-changes) data without assuming a bell curve.
- Dual Regulation Detection: Identifies factors that simultaneously activate some targets while repressing others.
- Robustness: Maintains performance even when data is subsampled or signals are damped.
Key Insights from Alzheimer’s Disease
The authors applied pyPAGE to bulk (MSBB) and single-cell (ROSMAP) RNA-seq datasets to study AD.
Transcriptional vs. Post-Transcriptional Regulation
A critical discovery was the divergence in regulatory mechanisms across cell types. AD-related changes in neurons are primarily driven at the transcriptional level. In contrast, changes in glial cells are heavily influenced by post-transcriptional regulation, such as RNA stability and splicing.
RBPs as Survival Predictors
RNA-binding proteins (RBPs) like LIN28A and HNRNPD emerged as vital players. Their activity levels were more predictive of patient survival than standard pathological scores like Braak (tau tangles) or Cerad (amyloid plaques). Patients with low RBP activity showed a hazard ratio of 4.84 for shorter survival (p=0.012).
Benchmarking and Performance
In simulations with added "promiscuity bias," pyPAGE significantly outperformed existing tools. While the performance of the original iPAGE dropped by 30%, pyPAGE remained stable with a PR-AUC of approximately 0.94.
The tool identified 15 Transcription Factors (TFs), 13 RBPs, and 8 miRNAs significantly associated with AD pathology. Notably, it revealed that SOX10 is specifically deregulated in oligodendrocytes, a detail often masked in bulk tissue analysis.
Conclusion and Future Directions
pyPAGE provides a robust, unbiased method for estimating the activity of transcriptional and post-transcriptional regulons. While it corrects for membership bias, it still depends on the quality of existing annotations. Future applications could focus on clinical stratification, using molecular subtypes to predict disease trajectory or select participants for targeted clinical trials.
Summary updated